
    
      In the present study, the patients with stage Ib2-IIa2 cervical cancer will receive either
      neoadjuvant chemo/brachytherapy or neoadjuvant chemotherapy before radical hysterectomy and
      pelvic+/- para-aortic lymph node dissection. According to the surgical findings,
      post-operative chemo-radiotherapy will be performed.
    
  